-
FDA Giving Fast-Track Review to Alzheimer’s Candidate
U.S. Food and Drug Administration is giving an accelerated review to a candidate drug designed to treat Alzheimer’s disease by reducing the toxicity of amyloid beta proteins making up the plaque accumulating in the brain.
-
PhRMA: 258 Vaccines in Clinical Development
An industry group of American pharmaceutical makers says its companies have 258 vaccines, including immunotherapies, in clinical trials or awaiting FDA approval.
-
Genome Engineering Streamlines E. Coli DNA
A genetics engineering team developed a technique for modifying the genome of E. coli bacteria to remove redundant DNA components, a step toward designing new organisms.
-
Safer Pain-Killing Drug Candidate Discovered
A research team from the U.S. and Germany identified a chemical molecule with pain-killing properties of opioids, but apparently without the dangerous side effects.
-
Phone-Linked Glucose Meter Shows Health, Monetary Benefits
The maker of a glucose meter that connects to cell-phone networks reports users of the device enjoy lower blood glucose readings and financial savings.
-
Computer Models to Boost 3-D Print Designs in Mfring
An academic-industry team is developing computer-based methods to improve the design for three-dimensional printing of complex manufactured items.
-
Leukemia Drug Shows Potential as Heart Attack Therapy
A new drug being tested as a leukemia treatment was shown in lab mice to reduce inflammatory white blood cells that lead to a build-up of arterial plaques and heart disease.
-
Robo-Bacteria Engineered for Cancer Drug Delivery
A biomedical engineering team designed a technology for precise deployment of drugs to tumors with bacteria modified to deliver their cargoes.
-
Gene Editing Negates Sickle Cell to Create Healthy Blood
Medical researchers developed a technique with genome editing to negate the effects of a mutation that causes inherited blood disorders like sickle cell disease.
-
Molecular Express, Baylor Medicine Partner on Vaccines
Vaccine developer Molecular Express and Baylor College of Medicine in Houston are developing boosters for vaccines from pieces of viruses that increase immune response to disease, including cancer.